Skip to main content
SpringerLink
Log in

Il ruolo dell’endocrinologo nella gestione dei pazienti trattati per leucemia mieloide cronica

  • ENDOCRINOLOGIA ONCOLOGICA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Saussele S, Krauss M-P, Hehlmann R et al. (2015) Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV. Blood 126(1):42–49. https://doi.org/10.1182/blood-2015-01-617993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vergès B, Walter T, Cariou B (2014) Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism. Eur J Endocrinol 170(2):R43–R55. https://doi.org/10.1530/EJE-13-0586

    Article  CAS  PubMed  Google Scholar 

  3. Iurlo A, Orsi E, Cattaneo D, Resi V, Bucelli C, Orofino N, Sciumè M, Elena C, Grancini V, Consonni D, Orlandi EM, Cortelezzi A (2015) Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem? Oncotarget 6(32):33944–33951. https://doi.org/10.18632/oncotarget.5580

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB (American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Hypertension, Council on Quality of Care and Outcomes Research, Council on Functional Genomics and Translational Biology) (2016) Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation 134(21):e468–e495

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SCDU Endocrinologia Oncologica, Dipartimento di Oncologia ed Ematologia, AOU Città della Salute e della Scienza–Presidio Molinette, Torino, Italia

    Marco Gallo, Alice Nervo, Valentina D’Angelo & Emanuela Arvat

  2. SC Ematologia, Dipartimento di Oncologia ed Ematologia, AOU Città della Salute e della Scienza–Presidio Molinette, Torino, Italia

    Patrizia Pregno

Authors
  1. Marco Gallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrizia Pregno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alice Nervo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valentina D’Angelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emanuela Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Gallo.

Ethics declarations

Conflitto di interesse

Gli autori dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gallo, M., Pregno, P., Nervo, A. et al. Il ruolo dell’endocrinologo nella gestione dei pazienti trattati per leucemia mieloide cronica. L'Endocrinologo 20 (Suppl 1), 27–29 (2019). https://doi.org/10.1007/s40619-019-00547-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-019-00547-8

Search

Navigation